Genertec Universal Medical Group Co (FRA:5UM) Marketable Securities: €1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5UM Genertec Universal Medical Group Co Ltd FRA:5UM
48 GF Score
Price €0.48
GF Value €0.48
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Genertec Universal Medical Group Co Marketable Securities?

Genertec Universal Medical Group Co FRA:5UM -0.41% 48 Marketable Securities is €1 Mil as of Dec. 2025. GuruFocus rates FRA:5UM with a GF Score™ of 48/100 and a GF Value™ of €0.48 (Fairly Valued). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Genertec Universal Medical Group Co's Marketable Securities for the quarter that ended in Dec. 2025 was €1 Mil.

Genertec Universal Medical Group Co's annual Marketable Securities declined from Dec. 2023 (€7 Mil) to Dec. 2024 (€0 Mil) but then increased from Dec. 2024 (€0 Mil) to Dec. 2025 (€1 Mil).

Genertec Universal Medical Group Co  (FRA:5UM) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Genertec Universal Medical Group Co Marketable Securities Related Terms

Genertec Universal Medical Group Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Genertec Universal Medical Group Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genertec Universal Medical Group Co Marketable Securities Chart

Genertec Universal Medical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 7.29 0.17 1.18

Genertec Universal Medical Group Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.29 1.33 0.17 0.08 1.18
FRA:5UM
48GF Score
Genertec Universal Medical Group Co Ltd FRA:5UM
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genertec Universal Medical Group Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €1 Mil mean?
Genertec Universal Medical Group Co (FRA:5UM) has a Marketable Securities of €1 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Genertec Universal Medical Group Co and its competitors.
Is Genertec Universal Medical Group Co's Marketable Securities too high?
Genertec Universal Medical Group Co's current Marketable Securities is €1 Mil. Overall, Genertec Universal Medical Group Co has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genertec Universal Medical Group Co's Marketable Securities compare to V and MA?
Genertec Universal Medical Group Co's Marketable Securities of €1 Mil can be compared against companies in the Credit Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Credit Services company?
A good Marketable Securities depends on the Credit Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Genertec Universal Medical Group Co and its competitors. Genertec Universal Medical Group Co's current Marketable Securities is €1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genertec Universal Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Genertec Universal Medical Group Co (FRA:5UM) is currently considered Fairly Valued. The stock's GF Value™ is €0.48, compared to a current price of €0.48 — trading 0.4% above its estimated fair value. The current Marketable Securities is €1 Mil. Genertec Universal Medical Group Co's overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Genertec Universal Medical Group Co (FRA:5UM), the current Marketable Securities is €1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genertec Universal Medical Group Co (FRA:5UM) Overvalued in 2026?

Based on GuruFocus' analysis, Genertec Universal Medical Group Co stock appears to be overvalued. The current stock price of €0.48 is trading 0.4% above its estimated GF Value™ of €0.48. GuruFocus considers Genertec Universal Medical Group Co to be Fairly Valued.

Key valuation signals for FRA:5UM:

  • Marketable Securities: €1 Mil
  • GF Value™: €0.48 vs. price of €0.48 (0.4% above fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the FRA:5UM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genertec Universal Medical Group Co Business Description

Other Exchanges 02666:Hong Kong
Address No. 90, Side Road of West Third Ring Middle Road, 20th to 28th Floor, Fengtai District, Beijing, CHN
Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The group has two business segments namely The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services; and Healthcare business comprises includes hospital group business, healthcare technology business and specialty business. Geographically, it derives a majority of its revenue from Mainland China.
48GF Score

Get the complete analysis for FRA:5UM

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.48
Price
€0.48
GF Value